Evommune, Inc. Common Stock (EVMN)

Investing Cash Flow

$31.29M

Quarterly · Period ending: · USD

EVMN logo

EVMN Investing Cash Flow

Latest reported$31.29M
EVMN Quarterly Cash from Investing ($9.65M → $31.29M)
High-resolution chart · PNG

EVMN investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
31,294,000
-85,359,000
-122,901,000
-23,906,000
18,000,000
13,500,000
-33,080,000
9,412,000
10,027,000
9,648,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.